Sciensus support a number of phase II to IV clinical trials, insight studies and early access schemes. Our service allows patients to access clinical trials and early access schemes quickly, relieving capacity challenges within NHS and CROs. We then support patients with adherence to protocols including our digital pathways.
To do this, our UK wide national footprint reaches patients quickly. Whereby our centralised pharmacy holds and supplies temperature tracked IMP or early access medicines direct to patients via our own GDP logistics.
We have full regulatory compliance including Sciensus teams all having GCP training and trial specific training. Our nursing team provide patient counselling, IMP administration, and take patient observations including clinical samples. We can also capture patient insight including patient reported outcomes measures (PROMs).
Across our business, we currently have over 240,000 patients and we have completed over 100 clinical trials and access schemes. Utilising our UK wide footprint, including relationships with all NHS Hospitals, thousands of consultants and many pharmaceutical companies